文献速递血液透析通路

从「内瘘优先」缓慢转向个体化透析通路规划

Slowly moving the needle away from Fistula First.
PubMed 文献 · J Vasc Surg · 2023-11-10

本研究回顾性分析单中心2021年前创建的401例动静脉内瘘,评估「内瘘优先」时代的并发症与手术无效性。结果显示52%的 cohort 出现手术无效,80岁以上患者主要并发症风险更高,术前已建立导管透析是唯一独立保护因素。作者认为应从「内瘘优先」转向「终末期肾病生命规划」以更贴合个体需求。

要点

  • 401例动静脉内瘘中52%出现手术无效,包括40%内瘘未成熟。
  • 80岁以上患者围术期心脏事件发生率19% vs 8%(P = .004)。
  • 术前已建立导管透析是手术无效的唯一独立保护因素(OR 0.36)。

核心结论

  • 在激进的「内瘘优先」时代,约50%的初次动静脉内瘘手术被视为无效。
  • 80岁以上患者在则该时代尤其容易出现无效手术和并发症。
  • 作者希望从「内瘘优先」转向「终末期肾病生命规划」,以更周全地将血管通路策略与个体患者需求相匹配。

研究设计与样本

  • 回顾性评估单中心2021年前连续创建的动静脉内瘘患者的并发症和死亡率,并界定手术无效性。

主要发现

  • 共创建401例动静脉内瘘,包括桡动脉-头静脉(44%)、肱动脉-头静脉(41%)和肱动脉-贵要静脉(15%)构建。
  • 患者平均年龄69 ± 15岁,63%为男性,74%在内瘘创建时已在接受血液透析。
  • 45例患者(11%)发生心脏事件,5例患者(1%)在通路手术后90天内死亡。
  • 围术期心脏事件在80岁以上患者中显著更常见(19% vs 8%;P = .004)。
  • 年龄>80岁是90天主要并发症的独立预测因素(OR 1.88;95%CI 1.04-3.39;P = .036),也是第一年内主要发病率(定义为心肺并发症、卒中或死亡)的唯一独立预测因素(OR 2.01;95%CI 1.24-3.25;P = .004)。

关键数值与推荐

  • 手术无效定义为:从未使用的内瘘、未开始透析、尽管进行二次干预仍成熟失败、需要结扎的血液透析通路诱导的远端缺血、次级通畅性早期丧失和/或术后前6个月内患者死亡。
  • 手术无效发生在52%的队列中(n = 208例患者):40%(n = 160)的初次动静脉内瘘尽管辅助仍未能成熟,19%(n = 77)在6个月时失去次级通畅性,13%的患者(n = 53)在通路创建后从未开始透析,4%(n = 16)在6个月时死亡,2%的动静脉内瘘(n = 10)成熟但从未被使用,2%(n = 9)因血液透析通路诱导的远端缺血需要结扎。
  • 手术无效的唯一独立保护因素是动静脉内瘘创建前已建立导管透析(OR 0.36;95%CI 0.22-0.59;P < .01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2019, the management of end-stage kidney disease (ESKD) shifted away from "Fistula First" (FF) to "ESKD Life-Plan: Patient Life-Plan First then Access Needs." Indeed, some patients exhibit such excessive comorbidity that even relatively minor vascular surgery may be complicated. The purpose of this study was to retrospectively assess complications and mortality (and delineate operative futility) in patients undergoing arteriovenous fistula (AVF) creation in the FF era. METHODS: Consecutive AVFs created in a single institution before 2021 were retrospectively reviewed. Operative futility was defined as never-accessed fistula, no initiation of dialysis, failure of access maturation (despite secondary intervention), hemodialysis access-induced distal ischemia requiring ligation, early loss of secondary patency, and/or patient mortality within the first 6 postoperative months. RESULTS: A total of 401 AVFs were created including radial-cephalic (44%), brachial-cephalic (41%), and brachial-basilic (15%) constructions. Patients exhibited a mean age of 69 ± 15 years; 63% were male, and most (74%) were already being hemodialyzed at the time of fistula creation. Forty-five patients (11%) suffered a cardiac event, and five patients died (1%) within 90 days of their access surgery. Perioperative cardiac events were significantly more common after age 80 (19% vs 8%; P = .004); age >80 years was an independent predictor of major 90-day complications (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.04-3.39; P = .036) and the sole independent predictor of major morbidity defined as cardiopulmonary complications, stroke, or death within the first year (OR, 2.01; 95% CI, 1.24-3.25; P = .004). Operative futility was encountered in 52% of the cohort (n = 208 patients): 40% (n = 160) of primary AVFs failed to mature despite assistance, 19% (n = 77) had lost secondary patency by 6 months, 13% of patients (n = 53) were never started on dialysis after access creation, 4% (n = 16) were dead by 6 months, 2% of AVFs (n = 10) matured but were never accessed, and 2% (n = 9) required ligation for hemodialysis access-induced distal ischemia. Not surprisingly, the sole independent protector against operative futility was that catheter-based dialysis had been established prior to AVF creation (OR, 0.36; 95% CI, 0.22-0.59; P < .01). CONCLUSIONS: Approximately 50% of primary AVF operations performed in the aggressive FF era were deemed futile. Octogenarians were particularly prone to futility and complications during this era. A paradigm shift, from FF to an "ESKD Life-Plan" will, hopefully, more thoughtfully match vascular access strategies to individual patient needs.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ghandour H, Cataneo JL, Asha A, et al. Slowly moving the needle away from Fistula First. J Vasc Surg. 2023. PMID: 37952784. doi:10.1016/j.jvs.2023.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。